Risk signal mining related to lenvatinib based on the US FDA adverse event reporting system
ZHAO Xiaohong, GUO Mingxing, WANG Xiaojian, LIN Jianrui, CUI Xiangli
Chinese Journal of Pharmacovigilance . 2022, (11): 1233 -1237 .  DOI: 10.19803/j.1672-8629.20210561